WST Financial Facts
Income tax expense: 14.4MGross profit: 121.1M
See Full Income Statement
Pension and other postretirement benefits: 5.7M
Commitments and contingencies (Note 13): 0
See Full Balance Sheet
West Pharmaceutical Services, Inc. (WST) Earnings
|
Expand Research on WST
| Next EPS Date | 4/25/24 | EPS Growth Rate | -34.3% |
|---|---|---|---|
| Average EPS % Beat Rate | +11.9% | Revenue Growth Rate | -6.5% |
| Average % Move 1-Wk after EPS | -5.5% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
4/25/24  |
Q124 | N/A | $1.30 | N/A | N/A | $670.31M | = | N/A | N/A | ||
| 7/31/13 |
 |
Q213 | N/A | $0.82 | N/A | N/A | $349.85M |  |
N/A | N/A | |
| 5/1/14 |
|
Q114 | $0.38 | $0.41 | -$0.03 | $346.8M | $340.9M | = |  | | Details |
| 2/20/14 |
|
Q413 | $0.38 | $0.38 | $0.00 | $342.7M | $348.7M | = | | | Details |
| 2/17/11 |
|
Q410 | $0.42 | $0.46 | -$0.04 | $276.8M | $272.92M | = | | | Details |
| 10/30/14 |
|
Q314 | $0.44 | $0.43 | +$0.01 | $355.9M | $356.08M | = | | | Details |
| 10/29/15 |
|
Q315 | $0.44 | N/A | N/A | $344.5M | $355.9M | = | | | Details |
| 2/19/15 |
|
Q414 | $0.45 | $0.46 | -$0.01 | $349.8M | $348.33M | = | | | Details |
